Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.76 |
| ▸ | DNM1 | Q05193 | 10/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.39 |
| ▸ | LSS | P48449 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1133673 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL31473002 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL10389453 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL10580785 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL10579961 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL10579987 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL1133981 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL10606386 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL234192 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL30276919 | 1.00 | LMNA (0.76) | LMNADNM1HTTPLA2G1BHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4165152-A1 | TEXTILE TREATMENT COMPOSITIONS | Enviro Specialty Chemicals Inc. (US) | 2023-04-19 | — | — | EP | claimed |
| WO-2018160865-A1 | ACTIVE TARGETING OF CELLS BY MONOSIZED PROTOCELLS | BRINKER CHARLES JEFFREY (US) | 2018-09-07 | — | — | WO | claimed |
| US-20160287717-A1 | Core and Surface Modification of Mesoporous Silica Nanoparticles to Achieve Cell Specific Targeting In Vivo. | STC UNM (US) | 2016-10-06 | — | — | US | claimed |
| EP-3046547-A1 | CORE AND SURFACE MODIFICATION OF MESOPOROUS SILICA NANOPARTICLES TO ACHIEVE CELL SPECIFIC TARGETING IN VIVO | STC.UNM (US) | 2016-07-27 | — | — | EP | claimed |
| WO-2015042268-A1 | CORE AND SURFACE MODIFICATION OF MESOPOROUS SILICA NANOPARTICLES TO ACHIEVE CELL SPECIFIC TARGETING IN VIVO | STC.UNM (US) | 2015-03-26 | — | — | WO | claimed |
| WO-2013110614-A1 | METHOD FOR CLEANING A LAUNDRY WASHING MACHINE AND LAUNDRY WASHING MACHINE IMPLEMENTING THE METHOD | ELECTROLUX HOME PRODUCTS CORPORATION N.V. (BE) | 2013-08-01 | — | — | WO | claimed |
| EP-2620536-A1 | Method for cleaning a laundry washing machine and laundry washing machine implementing the method | Electrolux Home Products Corporation N.V. (BE) | 2013-07-31 | — | — | EP | claimed |
| JP-61005086-A | — | — | None | — | — | JP | disclosed |
| WO-2024182425-A1 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES/DISORDERS | NOUREDDINE ACHRAF (US) | 2024-09-06 | — | — | WO | disclosed |
| EP-4165152-A1 | TEXTILE TREATMENT COMPOSITIONS | Enviro Specialty Chemicals Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| US-11344629-B2 | Active targeting of cells by monosized protocells | BRINKER CHARLES JEFFREY (US) | 2022-05-31 | — | — | US | disclosed |
| US-20210395652-A1 | TEXTILE TREATMENT COMPOSITIONS | ANGRES, ISAAC A, PHD | 2021-12-23 | — | — | US | disclosed |
| WO-2021253015-A1 | TEXTILE TREATMENT COMPOSITIONS | ENVIRO SPECIALTY CHEMICALS INC (US) | 2021-12-16 | — | — | WO | disclosed |
| EP-1610828-A1 | AN ANTIMICROBIAL SUBSTRATE, A METHOD AND A COMPOSITION FOR PRODUCING IT | Appeartex AB (SE) | 2006-01-04 | — | — | EP | disclosed |
| WO-2004087226-A1 | AN ANTIMICROBIAL SUBSTRATE, A METHOD AND A COMPOSITION FOR PRODUCING IT | APPEARTEX AB (SE) | 2004-10-14 | — | — | WO | disclosed |
| EP-0264400-B1 | SYNTHESIZING PROCESS | SANITIZED AG (CH) | 1989-10-04 | — | — | EP | disclosed |
| US-4845256-A | Production of silyl quaternary ammonium compounds | SANITIZED AG (CH) | 1989-07-04 | — | — | US | disclosed |
| EP-0264400-A1 | SYNTHESIZING PROCESS. | SANITIZED AG (CH) | 1988-04-27 | — | — | EP | disclosed |
| WO-1987006587-A1 | SYNTHESIZING PROCESS | SANITIZED AG (CH) | 1987-11-05 | — | — | WO | disclosed |
| JP-S615086-A | TRIALKYLTRIMETHOXYSILYLPROPYLAMMONIUM HALIDE AND ANTIFUNGAL COMPOSITION CONTAINING THE SAME | KOSHII PUREZAABINGU:KK | 1986-01-10 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395652-A1 | TEXTILE TREATMENT COMPOSITIONS | PPM1D, SMARCC2, REV1 | LMNA 3758/4885DNM1 939/4885HTT 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.